The last illustration is showing what occurs when we insert a dopamine blocker in the tuberoinfundibular pathway which we see when we insert that dopamine blocker and reduce dopamine in this pathway on a non-selective basis we see elevation in Prolactin levels, which can cause some of the gynocamastia issues in both men and women. 